ChemicalBook > CAS DataBase List > Satralizumab Linker

Satralizumab Linker

Product Name
Satralizumab Linker
CAS No.
1491917-83-9
Chemical Name
Satralizumab Linker
Synonyms
Trodelvy;Satralizumab Linker;Sacituzumab Govitecan;Sacituzumab govitecan (ADC)
CBNumber
CB65849367
Formula Weight
0
MOL File
Mol file
More
Less

Satralizumab Linker Property

form 
Solid
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H341Suspected of causing genetic defects

H360May damage fertility or the unborn child

H373May cause damage to organs through prolonged or repeated exposure

Precautionary statements

P201Obtain special instructions before use.

P202Do not handle until all safety precautions have been read and understood.

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P281Use personal protective equipment as required.

P308+P313IF exposed or concerned: Get medical advice/attention.

P314Get medical advice/attention if you feel unwell.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

Satralizumab Linker Chemical Properties,Usage,Production

Uses

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity[1].

Mechanism of action

Through the targeting effect of antibodies, Sacituzumab Govitecan delivers SN-38 directly to tumor cells expressing Trop-2. SN-38 is a topoisomerase I inhibitor that can cause DNA double-strand breaks, thereby inhibiting the replication and division of tumor cells.

Synthesis

The lysine derivative 321 was coupled with p-aminobenzyl alcohol, followed by the removal of the carbamate protecting group to afford the α-aminoamide 323. This amine was then coupled with the commercial α,ο-hydrazide 325 to afford the benzyl alcohol 323 in excellent yield. The benzyl alcohol 323 was then reacted with the chloroformate 320 under mild alkaline conditions to afford the carbonate 326. The removal of the silyl ether protecting group under acidic conditions, followed by click cyclization with the alkyne 327 and the removal of the trityl protection in 326, ultimately afforded CL2A-SN-38 (328) in excellent yield. The disulfide bonds of the Trop-2 antibody were first cleaved using tris(2-carboxyethyl)phosphine (TCEP) as a reducing agent. The cleaved disulfide Trop-2 antibody was then reacted with CL2A-SN-38, followed by a clearance reaction using N-ethylmaleimide. This series of reactions resulted in a Michael addition reaction on the reduced antibody, which proceeded at a stoichiometric ratio of approximately 7.6. Through these steps, Sacituzumab Govitecan was finally obtained.

in vivo

Sacituzumab govitecan (IMMU-132) (17.5 mg/kg; twice weekly for 4 weeks) produces significant antitumor effects in mice bearing human gastric cancer xenografts[1].

References

[1] Cardillo TM, et al. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug Chem. 2015 May 20;26(5):919-31. DOI:10.1021/acs.bioconjchem.5b00223
[2] Goldenberg DM, Cardillo TM, Govindan SV, Rossi EA, Sharkey RM. Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) [published correction appears in Oncotarget. 2020 Mar 10;11(10):942]. Oncotarget. 2015;6(26):22496-22512. DOI:10.18632/oncotarget.4318
[3] Cardillo TM, et al., Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug Chem. 2015 May 20;26(5):919-31. DOI:10.1021/acs.bioconjchem.5b00223

Satralizumab Linker Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Satralizumab Linker Suppliers

Chengdu Pukang Biotechnology Co., Ltd
Tel
+86-028-82550498 +86-19102685862
Fax
086-28-82550468
Email
sales@pu-kang.com
Country
China
ProdList
497
Advantage
58
Chengdu Pukang Biotechnology Co., Ltd
Tel
028-82550498
Email
export@pu-kang.com
Country
CHINA
ProdList
210
Advantage
58
Shanghai Inchman Chemical Technology Co., LTD
Tel
18299177127
Email
info@richmanchem.com
Country
China
ProdList
3000
Advantage
58
Wuhan Peptide Core Biotechnology Co., Ltd
Tel
027-65317797 13667154760
Email
1096814016@qq.com
Country
China
ProdList
10711
Advantage
58
Chengdu Hanwei Biotechnology Co., Ltd
Tel
17360178904 18217049878
Email
zengzongwen@pegtide.com
Country
China
ProdList
1222
Advantage
58
bioleaper
Tel
4000880777 17585207275
Email
guojing@bioleaper.com
Country
China
ProdList
5616
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
10001
Advantage
58
Sichuan jiayinglai technology CO.,LTD
Tel
028-64159575
Email
1678230860@qq.com
Country
China
ProdList
6511
Advantage
58
Hangzhou Starter Biotechnology Co Ltd
Tel
0571-8756-5022
Email
order@starter-bio.com
Country
China
ProdList
5767
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58

1491917-83-9, Satralizumab LinkerRelated Search:


  • Satralizumab Linker
  • Sacituzumab Govitecan
  • Sacituzumab govitecan (ADC)
  • Trodelvy
  • 1491917-83-9
  • satralizumab